Earnings Preview: ADMA Biologics
Portfolio Pulse from Benzinga Insights
ADMA Biologics is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.01. The company's past performance shows a pattern of share price increases following earnings reports, even when EPS estimates were missed. The stock is currently trading at $3.63 and has seen a 48.79% increase over the last 52-week period.
November 07, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ADMA Biologics is expected to report an EPS of $-0.01 in its upcoming earnings report. The company's stock has historically increased following earnings reports, suggesting potential positive short-term impact.
ADMA Biologics has a history of its stock price increasing following earnings reports, even when the company has missed EPS estimates. This suggests that investors may react positively to the upcoming earnings report, potentially leading to a short-term increase in the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100